This Article Full Text Full Text (PDF) All Versions of this Article: 43/2/460    most recent 01.HYP.0000110907.33263.0bv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Langenickel, T. Articles by Bader, M. Search for Related Content PubMed PubMed Citation Articles by Langenickel, T. Articles by Bader, M. Related Collections Cell signalling/signal transduction

(Hypertension. 2004;43:460.)
© 2004 American Heart Association, Inc.

Scientific Contribution

Forced Homodimerization by Site-Directed Mutagenesis Alters Guanylyl Cyclase Activity of Natriuretic Peptide Receptor B

Thomas Langenickel; Jens Buttgereit; Ines Pagel; Rainer Dietz; Roland Willenbrock; Michael Bader

From the Max Delbrueck Center for Molecular Medicine (T.L., J.B., M.B.), Berlin-Buch, and the Franz-Volhard-Clinic (I.P., R.D., R.W.), Humboldt University, Charité Campus Berlin-Buch, Berlin, Germany.

Correspondence to Thomas Langenickel, MD, National Heart, Lung, and Blood Institute, 50 Center Dr, Bldg 50/4529, Bethesda, MD 20892. langenit{at}nhlbi.nih.gov or Michael Bader, PhD, Max-Delbrueck-Center for Molecular Medicine (MDC) Berlin-Buch, Robert-Rössle-Str 10, 13092 Berlin, Germany. mbader@mdc-berlin.de

Natriuretic peptides mediate their physiologic effects through activation of membrane-bound, guanylyl cyclase–coupled receptors (NPRs). Receptor dimerization is an important feature of signal transduction. This study was aimed at characterizing structurally important residues of the extracellular ligand-binding domain of NPR-B for receptor dimerization and cGMP generation. Deletion mutagenesis was used to replace cysteine residues at positions 53 (C53S), 417 (C417S), and 426 (C426S) by serine. Receptor expression, dimerization, whole-cell cGMP response, and guanylyl cyclase activity of membrane fractions were determined in stably transfected COS-7 cells. C53S, C417S, and C426S mutants were expressed and found to form disulfide-bridged covalent dimers. In contrast to NPR-B and C53S, C417S and C426S mutants displayed constitutive activity in whole cells (C417S, 146±12%, P<0.01; C426S, 153±7% of ligand-independent NPR-B cGMP generation, P<0.01). The cGMP response of C417S and C426S mutants in whole cells was dose dependent and 4 times lower than that in NPR-B, whereas it was blunted in C53S-transfected cells (1 µmol/L CNP, NPR-B 2868±436%; C53S, 206±16% of control, P<0.001 vs NPR-B, C417S, and C426S). Guanylyl cyclase assay in transfected cells confirmed the constitutive activity of C417S and C426S mutants. These data suggest that receptor dimerization by covalent disulfide bridges alters ligand-independent as well as ligand-dependent receptor activity. Localization of the crosslink in relation to the cell membrane is important for configuration of the extracellular domain and the consecutive signal transduction.

Key Words: natriuretic peptides • receptors, natriuretic peptides • cyclic GMP • signal transduction

This article has been cited by other articles:

				A. M. Richards Natriuretic Peptides: Update on Peptide Release, Bioactivity, and Clinical Use Hypertension, July 1, 2007; 50(1): 25 - 30. [Full Text] [PDF]

				T. H. Langenickel, J. Buttgereit, I. Pagel-Langenickel, M. Lindner, J. Monti, K. Beuerlein, N. Al-Saadi, R. Plehm, E. Popova, J. Tank, et al. Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B PNAS, March 21, 2006; 103(12): 4735 - 4740. [Abstract] [Full Text] [PDF]

				L. R. Potter, S. Abbey-Hosch, and D. M. Dickey Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions Endocr. Rev., February 1, 2006; 27(1): 47 - 72. [Abstract] [Full Text] [PDF]